ARPC5L

gene
On this page

Also known as MGC3038ARC16-2

Summary

ARPC5L (actin related protein 2/3 complex subunit 5 like, HGNC:23366) is a protein-coding gene on chromosome 9q33.3, encoding Actin-related protein 2/3 complex subunit 5-like protein (Q9BPX5). May function as component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks.

Predicted to enable actin filament binding activity. Predicted to be involved in Arp2/3 complex-mediated actin nucleation and cell migration. Located in extracellular exosome and focal adhesion.

Source: NCBI Gene 81873 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 23 total
  • Druggable target: yes
  • MANE Select transcript: NM_030978

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:23366
Approved symbolARPC5L
Nameactin related protein 2/3 complex subunit 5 like
Location9q33.3
Locus typegene with protein product
StatusApproved
AliasesMGC3038, ARC16-2
Ensembl geneENSG00000136950
Ensembl biotypeprotein_coding
Entrez81873

Gene structure

Transcript identifiers

Ensembl transcripts: 6 — 5 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000259477, ENST00000353214, ENST00000465124, ENST00000866775, ENST00000911390, ENST00000964188

RefSeq mRNA: 1 — MANE Select: NM_030978 NM_030978

CCDS: CCDS6859

Canonical transcript exons

ENST00000353214 — 6 exons

ExonStartEnd
ENSE00000806655124873692124873764
ENSE00001379505124868428124869439
ENSE00001397399124876878124877733
ENSE00001404537124862130124862398
ENSE00001432409124863988124864107
ENSE00003693470124874975124875151

Expression profiles

Bgee: expression breadth ubiquitous, 292 present calls, max score 99.35.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 46.6947 / max 431.3695, expressed in 1827 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
9849144.68541826
984891.9801921
984920.02147
984900.00783

Top tissues by expression

292 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
secondary oocyteCL:000065599.35gold quality
middle temporal gyrusUBERON:000277198.22gold quality
adult organismUBERON:000702397.33gold quality
gingival epitheliumUBERON:000194997.25gold quality
esophagus squamous epitheliumUBERON:000692097.18gold quality
right testisUBERON:000453497.07gold quality
gingivaUBERON:000182897.04gold quality
endothelial cellCL:000011597.03gold quality
left testisUBERON:000453397.03gold quality
lower esophagus mucosaUBERON:003583497.01gold quality
Brodmann (1909) area 23UBERON:001355497.00gold quality
epithelium of esophagusUBERON:000197696.94gold quality
squamous epitheliumUBERON:000691496.77gold quality
pharyngeal mucosaUBERON:000035596.75gold quality
dorsolateral prefrontal cortexUBERON:000983496.62gold quality
right frontal lobeUBERON:000281096.56gold quality
oocyteCL:000002396.49gold quality
esophagus mucosaUBERON:000246996.45gold quality
tendon of biceps brachiiUBERON:000818896.38gold quality
cingulate cortexUBERON:000302796.37gold quality
anterior cingulate cortexUBERON:000983596.37gold quality
mammalian vulvaUBERON:000099796.25gold quality
frontal cortexUBERON:000187096.25gold quality
frontal lobeUBERON:001652596.25gold quality
prefrontal cortexUBERON:000045196.23gold quality
Brodmann (1909) area 9UBERON:001354096.23gold quality
Brodmann (1909) area 46UBERON:000648396.21gold quality
primary visual cortexUBERON:000243696.10gold quality
mucosa of transverse colonUBERON:000499196.08gold quality
ponsUBERON:000098896.05gold quality

Single-cell (SCXA)

Detected in 6 experiment(s), a significant marker in 5.

ExperimentMarker?Max mean expression
E-MTAB-9467yes33.64
E-MTAB-10287yes28.29
E-MTAB-10042yes12.00
E-MTAB-10553yes7.44
E-MTAB-6379no1051.91
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

51 targeting ARPC5L, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-126-5P100.0072.713180
HSA-MIR-548AN99.9770.912817
HSA-MIR-96-5P99.9572.802140
HSA-MIR-545-3P99.9570.742783
HSA-MIR-391099.9571.132227
HSA-MIR-1213399.9271.822006
HSA-MIR-1271-5P99.9171.991972
HSA-MIR-329-3P99.9166.561234
HSA-MIR-362-3P99.9166.381267
HSA-MIR-10523-5P99.9169.222038
HSA-MIR-95-5P99.8972.173973
HSA-MIR-4697-3P99.8967.091123
HSA-MIR-449699.8868.892236
HSA-MIR-469899.8471.414303
HSA-MIR-4659A-3P99.8072.624248
HSA-MIR-4659B-3P99.8072.624248
HSA-MIR-6887-3P99.6667.831778
HSA-MIR-4690-5P99.6566.24813
HSA-MIR-651-5P99.6468.491104
HSA-MIR-426199.5970.303415
HSA-MIR-6758-3P99.5767.551078
HSA-MIR-513C-5P99.5068.421730
HSA-MIR-514B-5P99.5068.191766
HSA-MIR-5009-3P99.4569.431341
HSA-MIR-942-5P99.4168.401977
HSA-MIR-519D-5P99.4169.302057
HSA-MIR-3140-5P99.3969.041136
HSA-MIR-3191-5P99.2466.521722
HSA-MIR-429199.2068.882969
HSA-MIR-361-3P99.1966.451381

Cross-species orthologs

8 orthologs

OrganismSymbolGene ID
danio_rerioarpc5lbENSDARG00000035433
danio_rerioarpc5laENSDARG00000041720
mus_musculusArpc5lENSMUSG00000026755
rattus_norvegicusArpc5lENSRNOG00000014317
rattus_norvegicusArpc5l-ps1ENSRNOG00000067388
drosophila_melanogasterArpc5FBGN0031437
caenorhabditis_elegansarx-7WBGENE00000205
caenorhabditis_elegansC46H11.3WBGENE00016729

Paralogs (1): ARPC5 (ENSG00000162704)

Protein

Protein identifiers

Actin-related protein 2/3 complex subunit 5-like proteinQ9BPX5 (reviewed: Q9BPX5)

Alternative names: Arp2/3 complex 16 kDa subunit 2

All UniProt accessions (2): A0A024R897, Q9BPX5

UniProt curated annotations — full annotation on UniProt →

Function. May function as component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks.

Subunit / interactions. May be a component of the Arp2/3 complex in which it may replace ARPC5.

Subcellular location. Cytoplasm. Cytoskeleton.

Similarity. Belongs to the ARPC5 family.

RefSeq proteins (1): NP_112240* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR006789ARPC5Family
IPR036743ARPC5_sfHomologous_superfamily

Pfam: PF04699

UniProt features (4 total): sequence conflict 2, chain 1, modified residue 1

Structure

Experimental structures (PDB)

3 structures.

PDBMethodResolution (Å)
9I2BELECTRON MICROSCOPY3
8P94ELECTRON MICROSCOPY3.3
6YW6ELECTRON MICROSCOPY4.2

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BPX5-F189.330.65

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 64

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 235 (showing top): RNGTGGGC_UNKNOWN, GOBP_REGULATION_OF_PROTEIN_POLYMERIZATION, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, NAGASHIMA_NRG1_SIGNALING_UP, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS, WEI_MYCN_TARGETS_WITH_E_BOX, GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE, GOBP_ACTIN_FILAMENT_ORGANIZATION, GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY, TGANTCA_AP1_C, RYTTCCTG_ETS2_B, GOMF_ACTIN_BINDING, BASAKI_YBX1_TARGETS_UP, MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN

GO Biological Process (3): cell migration (GO:0016477), regulation of actin filament polymerization (GO:0030833), Arp2/3 complex-mediated actin nucleation (GO:0034314)

GO Molecular Function (3): actin binding (GO:0003779), protein-macromolecule adaptor activity (GO:0030674), protein binding (GO:0005515)

GO Cellular Component (9): Arp2/3 protein complex (GO:0005885), focal adhesion (GO:0005925), cortical cytoskeleton (GO:0030863), extracellular exosome (GO:0070062), glutamatergic synapse (GO:0098978), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), actin cytoskeleton (GO:0015629), synapse (GO:0045202)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cytoskeleton2
cell motility1
regulation of actin polymerization or depolymerization1
actin filament polymerization1
regulation of protein polymerization1
actin nucleation1
cytoskeletal protein binding1
protein binding1
molecular adaptor activity1
binding1
actin cytoskeleton1
protein-containing complex1
cell-substrate junction1
cell cortex1
extracellular vesicle1
synapse1
intracellular anatomical structure1
cellular anatomical structure1
intracellular membraneless organelle1
cell junction1

Protein interactions and networks

STRING

1250 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ARPC5LARPC1BO15143909
ARPC5LARPC1AQ92747865
ARPC5LARPC3O15145816
ARPC5LARPC2O15144800
ARPC5LACTR3BQ9P1U1732
ARPC5LACTR3P32391660
ARPC5LACTR2P61160647
ARPC5LACTG1P02571632
ARPC5LWASLO00401481
ARPC5LSNX27Q96L92459
ARPC5LACTR3CQ9C0K3453
ARPC5LSPCS2Q15005447
ARPC5LSPCS3P12280438
ARPC5LWASP42768404
ARPC5LCFTRP13569375

IntAct

133 interactions, top by confidence:

ABTypeScore
ARPC1BARPC2psi-mi:“MI:0915”(physical association)0.920
ARPC1BARPC2psi-mi:“MI:0914”(association)0.920
ARPC4ARPC1Bpsi-mi:“MI:0914”(association)0.910
ARPC1AARPC2psi-mi:“MI:0914”(association)0.900
ARPC1AARPC2psi-mi:“MI:0915”(physical association)0.900
ARPC5LARPC4psi-mi:“MI:0915”(physical association)0.890
ARPC4ARPC5Lpsi-mi:“MI:0915”(physical association)0.890
ACTR3ARPC1Bpsi-mi:“MI:0914”(association)0.890
ARPC3ARPC1Bpsi-mi:“MI:0914”(association)0.880
ARPC5LARPC1Bpsi-mi:“MI:0914”(association)0.830
CFTRESYT2psi-mi:“MI:0914”(association)0.710
GADD45GARPC5Lpsi-mi:“MI:0915”(physical association)0.670

BioGRID (184): ARPC5L (Affinity Capture-RNA), ARPC5L (Affinity Capture-RNA), ARPC5L (Affinity Capture-MS), ARPC5L (Affinity Capture-MS), ACTR3 (Co-fractionation), ARPC1A (Co-fractionation), ARPC2 (Co-fractionation), ARPC4-TTLL3 (Co-fractionation), ARPC4 (Co-fractionation), ARPC5L (Co-fractionation), ARPC5L (Co-fractionation), ARPC5L (Co-fractionation), ARPC5L (Co-fractionation), CAPZB (Co-fractionation), ARPC5L (Affinity Capture-MS)

ESM2 similar proteins: A1C987, A1D9P1, A1L108, A3GGB4, A3LPQ8, A5DMM1, A5DPQ5, A6S043, B0YEH1, B3H6Y2, C4YCB9, G5EES6, O14164, O15511, O74432, O96626, P0CN46, P0CN47, P0CN54, P0CN55, P40518, P91167, Q09722, Q0CVT0, Q10316, Q1DP77, Q2H731, Q2U0Q9, Q3SYX9, Q4KLF8, Q4P0P0, Q4PHN4, Q4W9S8, Q4WDK4, Q5AX75, Q5E963, Q5R4M1, Q5R516, Q641B9, Q68FI4

Diamond homologs: A1L108, B3H6Y2, O15511, O96626, P91167, Q3SYX9, Q4KLF8, Q5E963, Q5R4M1, Q5R516, Q641B9, Q68FI4, Q6DE18, Q9BPX5, Q9CPW4, Q9D898, Q9M117, Q10316, P40518

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 109 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Parasite infection1262.0×4e-17
Leishmania phagocytosis1262.0×4e-17
Fcgamma receptor (FCGR) dependent phagocytosis1249.9×6e-16
RHO GTPases activate PAKs648.7×5e-08
RHO GTPases Activate WASPs and WAVEs1047.4×3e-13
EPHB-mediated forward signaling1039.6×2e-12
Regulation of actin dynamics for phagocytic cup formation1335.7×2e-15
FCGR3A-mediated phagocytosis1233.5×7e-14

GO biological processes:

GO termPartnersFoldFDR
Arp2/3 complex-mediated actin nucleation783.8×7e-10
platelet aggregation519.1×8e-04
neuron projection morphogenesis515.7×2e-03
cellular response to type II interferon511.8×4e-03
actin cytoskeleton organization98.1×4e-04
actin filament organization68.1×6e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

23 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance18
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

934 predictions. Top by Δscore:

VariantEffectΔscore
9:124863985:C:Gacceptor_gain1.0000
9:124863986:A:AGacceptor_gain1.0000
9:124863987:G:GGacceptor_gain1.0000
9:124863987:GCC:Gacceptor_gain1.0000
9:124863987:GCCA:Gacceptor_gain1.0000
9:124864104:CAAGG:Cdonor_loss1.0000
9:124864105:AAG:Adonor_loss1.0000
9:124864106:AGGTG:Adonor_loss1.0000
9:124864109:T:Adonor_loss1.0000
9:124874970:TGCAG:Tacceptor_loss1.0000
9:124874971:GCA:Gacceptor_loss1.0000
9:124874972:CA:Cacceptor_loss1.0000
9:124874972:CAGG:Cacceptor_gain1.0000
9:124874973:A:AGacceptor_gain1.0000
9:124874973:AG:Aacceptor_gain1.0000
9:124874973:AGG:Aacceptor_loss1.0000
9:124874973:AGGA:Aacceptor_gain1.0000
9:124874974:G:Aacceptor_loss1.0000
9:124874974:G:GGacceptor_gain1.0000
9:124874974:GG:Gacceptor_gain1.0000
9:124874974:GGA:Gacceptor_gain1.0000
9:124874974:GGAG:Gacceptor_gain1.0000
9:124874974:GGAGC:Gacceptor_gain1.0000
9:124875079:G:GTdonor_gain1.0000
9:124862231:G:GTdonor_gain0.9900
9:124862234:G:GTdonor_gain0.9900
9:124862254:G:GGdonor_gain0.9900
9:124862399:G:GTdonor_gain0.9900
9:124863983:CACA:Cacceptor_loss0.9900
9:124863985:CA:Cacceptor_loss0.9900

AlphaMissense

994 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
9:124869318:T:CF10L1.000
9:124869320:C:AF10L1.000
9:124869320:C:GF10L1.000
9:124875140:T:AW130R1.000
9:124875140:T:CW130R1.000
9:124869321:C:AR11S0.999
9:124875075:T:CL108S0.999
9:124875089:T:GY113D0.999
9:124875095:G:CG115R0.999
9:124875135:T:CL128P0.999
9:124875141:G:CW130S0.999
9:124875142:G:CW130C0.999
9:124875142:G:TW130C0.999
9:124875143:C:GH131D0.999
9:124876899:G:CG141R0.999
9:124876900:G:AG141D0.999
9:124876912:G:CR145T0.999
9:124876912:G:TR145I0.999
9:124876936:T:AV153D0.999
9:124869319:T:CF10S0.998
9:124873764:G:CK74N0.998
9:124873764:G:TK74N0.998
9:124875006:T:AL85H0.998
9:124875006:T:CL85P0.998
9:124875042:T:AV97E0.998
9:124875087:T:AI112N0.998
9:124875099:T:CF116S0.998
9:124875132:T:CL127S0.998
9:124875135:T:AL128H0.998
9:124875144:A:CH131P0.998

dbSNP variants (sampled 300 via entrez): RS1000070012 (9:124876698 C>T), RS1000199376 (9:124874615 G>A), RS1000368212 (9:124868841 C>T), RS1000408117 (9:124873867 G>C), RS1000527160 (9:124871304 G>A), RS1000693726 (9:124875464 A>G), RS1000820478 (9:124869933 G>A), RS1000933793 (9:124864470 T>A), RS1001238372 (9:124877709 A>AAAG), RS1001267089 (9:124868167 G>C), RS1001360537 (9:124873015 C>T), RS1001371271 (9:124862510 T>A), RS1001386188 (9:124864129 T>C), RS1001506741 (9:124862844 T>A), RS1001824326 (9:124869071 A>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL6066486 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

ChEMBL bioactivities

2 potent at pChembl≥5 of 2 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).

pChemblTypeValueUnitMolecule
7.58Kd26.29nMCHEMBL5653589
7.46ED5034.7nMCHEMBL5653589

PubChem BioAssay actives

1 with measured affinity, of 2 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.

CompoundAssayTypeValueUnit
4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide2147894: Binding affinity to human ARPC5L incubated for 45 mins by Kinobead based pull down assaykd0.0263uM

CTD chemical–gene interactions

45 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Fincreases expression, affects cotreatment, decreases expression2
bisphenol Adecreases expression, affects cotreatment2
Tobacco Smoke Pollutionincreases expression, affects expression2
Particulate Matterdecreases expression2
aristolochic acid Iincreases expression1
FR900359increases phosphorylation1
dicrotophosdecreases expression1
2,4,6-tribromophenolincreases expression1
alpha-pineneaffects cotreatment, decreases expression, increases abundance1
decabromobiphenyl etherincreases expression1
arseniteincreases reaction, affects binding1
sodium arseniteincreases expression1
butyraldehydeincreases expression1
tetrabromobisphenol Aincreases expression1
potassium chromate(VI)affects cotreatment, increases expression1
methacrylaldehydeaffects cotreatment, decreases expression, increases abundance1
epigallocatechin gallateaffects cotreatment, increases expression1
di-n-butylphosphoric acidaffects expression1
2-palmitoylglycerolincreases expression1
hexabrominated diphenyl ether 153increases expression1
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidinedecreases expression, increases response to substance1
bisphenol Saffects expression1
PCI 5002affects cotreatment, increases expression1
bisphenol AFincreases expression1
Acroleinaffects cotreatment, decreases expression, increases abundance1
Air Pollutantsaffects cotreatment, decreases expression, increases abundance1
Arsenicaffects methylation1
Dexamethasoneaffects cotreatment, decreases expression1
Diazinonincreases methylation1
Diethylstilbestroldecreases expression1

ChEMBL screening assays

1 unique, capped per target: 1 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL5650936BindingBinding affinity to human ARPC5L incubated for 45 mins by Kinobead based pull down assayNVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_B2S7Abcam HEK293T ARPC5L KOTransformed cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.